BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12959480)

  • 1. Factor V Leiden: a review of the literature.
    Ament L
    J Perinat Neonatal Nurs; 2003; 17(3):190-5. PubMed ID: 12959480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden mutation in pregnancy.
    Cohen SM
    J Obstet Gynecol Neonatal Nurs; 2004; 33(3):348-53. PubMed ID: 15180198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric implications of the factor V leiden mutation: a review.
    Bloomenthal D; Delisle MF; Tessier F; Tsang P
    Am J Perinatol; 2002 Jan; 19(1):37-47. PubMed ID: 11857095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden: impact on infusion nursing practice.
    Weinstein SM
    J Infus Nurs; 2009; 32(4):219-23. PubMed ID: 19606001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden mutation and pregnancy.
    Langan RC
    J Am Board Fam Pract; 2004; 17(4):306-8. PubMed ID: 15243022
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of factor V Leiden in maternal health and the outcome of pregnancy.
    Calderwood CJ; Greer IA
    Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis.
    Biron-Andreani C; Schved JF; Daures JP
    Thromb Haemost; 2006 Jul; 96(1):14-8. PubMed ID: 16807645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor V Leiden mutation and pregnancy complications].
    Abraitis V; Mongirdiene A; Mockeviciene A
    Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden mutation: a nursing perspective.
    Page MJ
    J Vasc Nurs; 1998 Dec; 16(4):73-7. PubMed ID: 10085870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
    Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
    Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy.
    Horton AL; Momirova V; Dizon-Townson D; Wenstrom K; Wendel G; Samuels P; Sibai B; Spong CY; Cotroneo M; Sorokin Y; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ;
    Obstet Gynecol; 2010 Mar; 115(3):521-525. PubMed ID: 20177282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
    Couto E; Nomura ML; Barini R; Pinto e Silva JL
    Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].
    Dulícek P; Malý J; Kalousek I; Beránek M; Pecka M
    Ceska Gynekol; 2005 Mar; 70(2):133-8. PubMed ID: 15918268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.